Fortune November 19, 2020

Health insurance companies will have to give their customers estimated out-of-pocket costs for prescription drugs and disclose to the public the negotiated prices they pay for drugs, under an unexpected new Trump administration rule.

The administration said those requirements, part of a broader rule issued Oct. 29 forcing health plans to disclose costs and payments for most health care services, will promote competition and empower consumers to make better medical decisions.

The new rule does not, however, apply to Medicare or Medicaid.

The drug price provisions, which would not begin until 2022, were a surprise because they were not included in the original proposed rule issued in 2019.

It’s the departing Trump administration’s most ambitious effort to illuminate the complex, secret, and...

 
Topics: Congress / White House, Govt Agencies, Healthcare System, Insurance, Payer, Pricing / Spending
Telehealth reimbursement parity spurs insurer concerns of overutilization
UnitedHealth launching post-discharge home program for group Medicare Advantage plans
Health Systems in 2030: Dutch Insurer Perspective
Congress: Act Now To Ensure Telehealth Access For Medicare Beneficiaries
Blue Health Intelligence, AnalyticsIQ to help fight health inequity by enhancing payer data

Today's Sponsors

Curation Health
Philips
HealthITq

Today's Sponsors

Holon
ClearDATA

Today's Sponsor

Qure4u

2020-11-19T22:51:55-05:00